Cancer cells detect that they are under attack from T cells by recognizing IFN-gamma, which leads to the expression of PD-L1 on the surface of cancer cells and in turn inactivates the antitumor T cell response by binding to PD-1 (CD279). This evidence concerns the gene IFNG and cancer.